Questions About Blood Cancer?
We’re here to help. Contact our Oncology Nurse Navigator, Alison Behm, RN, OCN, at 203-276-CARE. Press 1.
The Hematology Division at the Bennett Cancer Center uses multi-disciplinary teamwork inspired by the Planetree philosophy of putting you—our patient—first. The Hematology Division offers a comprehensive range of treatment options for:
We focus primarily on diagnosing, managing and treating your blood disorders. To ensure the best care possible for you, our team has trained and worked at the best cancer treatment facilities in the United States. In 2016, the Bennett Cancer Center and Stamford Hospital partnered with the Dana Farber Cancer Institute (DFCI)/Brigham and Women’s Hospital in Boston as a member of the Cancer Care Collaborative. This initiative, in conjunction with the Division’s longstanding membership in the Eastern Cooperative Oncology Group (ECOG), continues to assure that the Hematology Division at the Bennett Cancer Center will be able to provide cutting edge clinical research studies generally available only at academic centers to patients in Fairfield County and Westchester County.
As recognition of this level of expertise, two of our hematologists have won the prestigious Melville Magida award which honors the best Fairfield County physicians under age 40. They are the only two hematologists to have ever been recognized with this award.
Blood Disease and Disorders
Our team specializes in many diseases and disorders, from benign to malignant. But we don’t just treat your blood condition—we treat you, the whole person. Here’s a detailed breakdown of our areas of expertise.
Malignant hematology and stem cell disorders
- Acute and chronic leukemias
- Low grade, intermediate grade and high grade B and T cell non-Hodgkin's lymphomas
- Hodgkin's disease
- Primary central nervous system lymphomas
- Multiple myeloma
- Myelodysplastic disorders
- Mast cell disorders
- Aplastic anemia
- Paroxysmal nocturnal hemogloginuria
- Myeloproliferative disorders including polycythemia vera, myelofibrosis and essential thrombocythemia
- HIV-related malignancies
- Malignant stem cell disorders
Benign hematology and autoimmune diseases
- Low blood counts (cytopenias) including anemia, leukopenia/neutropenia and thrombocytopenia
- Sickle cell disease and sickle variants
- Alpha and beta thalassemia
- Other hemoglobinopathies
- Primary and secondary autoimmune hemolytic anemia, leukopenia/neutropenia, thrombocytopenia
- Red cell enzyme disorders
- Red cell membrane disorders
- Qualitative platelet disorders
- Cyclic neutropenia
- HIV-related benign hematology
- Hemolytic uremic syndrome
- Atypical hemolytic uremic
- Thrombotic thrombocytopenia purpura
- Congential hypercoagulable states
- Acquired hypercoagulable states
- Infertility related to hypercoagulability
- Obstetrical disorders associated with recurrent fetal loss related to hypercoagulability
- Acquired and inheritable von Willebrand disease.
- Acquired and inheritable factor VIII deficiency (Hemophilia A)
- Acquired and inheritable factor IX deficiency (Hemophilia B)
- Factor XI deficiency (Hemophilia C)
- Miscellaneous acquired and inheritable factor deficiencies
- Disorders of the fibrinolytic system
- Chronic disseminated intravascular coagulation
- Hereditary hemorrhagic telangiectasia (Osler Weber Rendu)